ORIC Pharmaceuticals Inc (ORIC)
8.68
-0.09
(-1.03%)
USD |
NASDAQ |
Apr 24, 09:55
ORIC Pharmaceuticals Total Assets (Quarterly): 252.01M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 252.01M |
| September 30, 2023 | 274.34M |
| June 30, 2023 | 291.82M |
| March 31, 2023 | 226.65M |
| December 31, 2022 | 247.18M |
| September 30, 2022 | 238.00M |
| June 30, 2022 | 259.68M |
| March 31, 2022 | 275.06M |
| December 31, 2021 | 298.64M |
| Date | Value |
|---|---|
| September 30, 2021 | 314.18M |
| June 30, 2021 | 268.23M |
| March 31, 2021 | 283.96M |
| December 31, 2020 | 299.00M |
| September 30, 2020 | 191.66M |
| June 30, 2020 | 201.52M |
| March 31, 2020 | 85.06M |
| December 31, 2019 | 94.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.06M
Minimum
Mar 2020
314.18M
Maximum
Sep 2021
241.24M
Average
259.68M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Geron Corp | 394.08M |
| Verastem Inc | 149.72M |
| Karyopharm Therapeutics Inc | 240.44M |
| Syndax Pharmaceuticals Inc | 612.88M |
| Arvinas Inc | 1.305B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.92M |
| Shareholders Equity (Quarterly) | 224.09M |